Kalvista Pharmaceuticals Inc (KALV) — Capital Reinvestment Ratio
Kalvista Pharmaceuticals Inc (KALV) has a Capital Reinvestment Ratio of 0.01x as of January 2018, meaning it reinvests 0% of its operating cash flow ($28.22 Million) in capital expenditures ($182.00K). Check KALV tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kalvista Pharmaceuticals Inc Capital Reinvestment Ratio (2018–2018)
This chart tracks Kalvista Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Kalvista Pharmaceuticals Inc (KALV) cash flow conversion.
Annual Capital Reinvestment Ratio for Kalvista Pharmaceuticals Inc (2018–2018)
Year-by-year Capital Reinvestment Ratio for Kalvista Pharmaceuticals Inc from 2018 to 2018. See Kalvista Pharmaceuticals Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.14x | $10.56 Million | $1.43 Million | — |